Clincosm LogoSign in Get a demo

allogeneic hematopoietic stem cell transplantation

Showing 1 - 25 of 41
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Allogeneic Hematopoietic Stem Cell Transplantation, Allogeneic Stem Cell Transplantation, Hematologic Malignancies Trial in

Not yet recruiting
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +2 more
  • Orange, California
    Chao Family Comprehensive Cancer Center, University of Californi
Aug 31, 2023

Allogeneic Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Suzhou

Recruiting
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +2 more
  • VEN+AZA+Modified BUCY
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Apr 10, 2023

Allogeneic Hematopoietic Stem Cell Transplantation, Acute Lymphoblastic Leukemia Trial in Suzhou (VEN+AZA+Modified BUCY)

Recruiting
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • Acute Lymphoblastic Leukemia
  • VEN+AZA+Modified BUCY
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Apr 10, 2023

Hematological Disease, Allogeneic Hematopoietic Stem Cell Transplantation Trial in Tianjin (Hetrombopag, )

Recruiting
  • Hematological Disease
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital, Chinese Acade
Feb 6, 2023

Chronic Graft-versus-Host-Disease, Allogeneic Hematopoietic Stem Cell Transplantation, Leukemia Trial

Not yet recruiting
  • Chronic Graft-versus-Host-Disease
  • +4 more
    • (no location specified)
    Jan 11, 2023

    Acute Myeloid Leukemia, Adult, Myelodysplastic Syndrome(MDS), Allogeneic Hematopoietic Stem Cell Transplantation Trial in Wuhan

    Recruiting
    • Acute Myeloid Leukemia, Adult
    • +2 more
    • Fludarabine and Busulfan
    • Fludarabine and Melphalan
    • Wuhan, Hubei, China
      Wuhan Union Hospital, Tongji Medical college, Huazhong Universit
    Jan 5, 2023

    CNS Leukemia, Allogeneic Hematopoietic Stem Cell Transplantation Trial in Xi'an (TBF regimen, modified BuCY2 regimen)

    Not yet recruiting
    • Central Nervous System Leukemia
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • TBF regimen
    • modified BuCY2 regimen
    • Xi'an, Shaanxi, China
      First Affiliated Hospital of Xi'an Jiaotong University
    Dec 26, 2022

    The Gut Microbiome in FLT3- AL Undergoing Allo-HSCT With Or

    Recruiting
    • Acute Leukemia
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • Guangzhou, Guangdong, China
      Department of Hematology,Nanfang Hospital, Southern Medical Univ
    Oct 28, 2022

    The Gut Microbiome and Sorafenib Maintenance Therapy in FLT3-ITD

    Recruiting
    • Acute Myeloid Leukemia With FLT3/ITD Mutation
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • Guangzhou, Guangdong, China
      Department of Hematology,Nanfang Hospital, Southern Medical Univ
    Oct 25, 2022

    The Gut Microbiome in FLT3-ITD+ AML Undergoing Allo-HSCT With Or

    Recruiting
    • Acute Myeloid Leukemia With FLT3/ITD Mutation
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • Guangzhou, Guangdong, China
      Department of Hematology,Nanfang Hospital, Southern Medical Univ
    Oct 25, 2022

    Myelodysplastic Syndrome, Allogeneic Hematopoietic Stem Cell Transplantation, Conditioning Trial in Guangzhou (Granulocyte

    Recruiting
    • Myelodysplastic Syndrome
    • +2 more
    • Granulocyte Colony-Stimulating Factor(G-CSF)
    • +5 more
    • Guangzhou, Guangdong, China
      Department of Hematology,Nanfang Hospital, Southern Medical Univ
    Jul 11, 2022

    Secondary Acute Myeloid Leukemia Evolving From MDS, Allogeneic Hematopoietic Stem Cell Transplantation, Conditioning Trial in

    Recruiting
    • Secondary Acute Myeloid Leukemia Evolving From MDS
    • +2 more
    • Granulocyte Colony-Stimulating Factor(G-CSF)
    • +4 more
    • Guangzhou, Guangdong, China
      Department of Hematology,Nanfang Hospital, Southern Medical Univ
    Jul 5, 2022

    Verification in Pediatric Chronic GvHD: ABLE 2.0 / PTCTC GVH

    Recruiting
    • Chronic Graft-versus-Host-Disease
    • +4 more
      • San Francisco, California
      • +15 more
      Jun 17, 2022

      Acute B Lymphoblastic Leukemia, Allogeneic Hematopoietic Stem Cell Transplantation Trial in Shanghai (Fludarabine)

      Recruiting
      • Acute B Lymphoblastic Leukemia
      • Allogeneic Hematopoietic Stem Cell Transplantation
      • Shanghai, China
        Shanghai General Hospital
      May 13, 2022

      Allogeneic Hematopoietic Stem Cell Transplantation in Reunion

      Not yet recruiting
      • Allogeneic Hematopoietic Stem Cell Transplantation
      • questionnaire
      • Saint-Pierre, France
        CHU de la Réunion
      Apr 14, 2022

      Acute-graft-versus-host Disease, Allogeneic Hematopoietic Stem Cell Transplantation Trial in Suzhou (Sitagliptin + Standard

      Recruiting
      • Acute-graft-versus-host Disease
      • Allogeneic Hematopoietic Stem Cell Transplantation
      • Sitagliptin + Standard Prophylaxis
      • Standard Prophylaxis
      • Suzhou, Jiangsu, China
        The First Affiliated Hospital of Soochow University, Jiangsu Ins
      Jan 13, 2022

      Hematologic Diseases, Graft Failure, Allogeneic Hematopoietic Stem Cell Transplantation Trial (haplo-SCT with PTCy)

      Not yet recruiting
      • Hematologic Diseases
      • +2 more
      • haplo-SCT with PTCy
      • (no location specified)
      Nov 8, 2021

      Allogeneic Hematopoietic Stem Cell Transplantation Trial in Giza (chest physical therapy, routine medical treatment)

      Completed
      • Allogeneic Hematopoietic Stem Cell Transplantation
      • chest physical therapy
      • routine medical treatment
      • Giza, Nnjkjk, Egypt
        Zizi Mohammed Ibrahim Ali
      Oct 21, 2021

      Hematologic Malignancy, Older Patients, Allogeneic Hematopoietic Stem Cell Transplantation Trial in Hangzhou, Ningbo, Wenzhou

      Recruiting
      • Hematologic Malignancy
      • +2 more
      • venetoclax combining with fludarabine and melphalan
      • Hangzhou, Zhejiang, China
      • +7 more
      Oct 20, 2021

      Allogeneic Hematopoietic Stem Cell Transplantation, CMV Infection Trial in Beijing (CMV-TCR-T cells)

      Recruiting
      • Allogeneic Hematopoietic Stem Cell Transplantation
      • CMV Infection
      • CMV-TCR-T cells
      • Beijing, Beijing, China
        Peking University Institute of Hematology,People's hospital Peki
      Oct 11, 2021

      Hematopoietic Stem Cell Transplantation, Allogeneic Hematopoietic Stem Cell Transplantation, Autologous Hematopoietic Stem Cell

      Recruiting
      • Hematopoietic Stem Cell Transplantation
      • +2 more
      • GSTA1 genotyping
      • Geneva, Switzerland
        Hôpitaux Universitaires de Genève
      Jul 30, 2021

      Myelodysplastic Syndrome, Allogeneic Hematopoietic Stem Cell Transplantation, Conditioning Trial in Guangzhou (Granulocyte

      Recruiting
      • Myelodysplastic Syndrome
      • +2 more
      • Granulocyte Colony-Stimulating Factor(G-CSF)
      • +4 more
      • Guangzhou, Guangdong, China
        Department of Hematology,Nanfang Hospital, Southern Medical Univ
      Jan 15, 2021

      Acute Myeloid Leukemia, Allogeneic Hematopoietic Stem Cell Transplantation, Conditioning Trial in Guangzhou (Decitabine,

      Unknown status
      • Acute Myeloid Leukemia
      • +3 more
      • Guangzhou, Guangdong, China
        Department of Hematology,Nanfang Hospital, Southern Medical Univ
      Dec 18, 2020

      Allogeneic Hematopoietic Stem Cell Transplantation Trial in Milwaukee (MLN9708)

      Completed
      • Allogeneic Hematopoietic Stem Cell Transplantation
      • Milwaukee, Wisconsin
        Froedtert Hospital and the Medical College of Wisconsin
      Nov 1, 2020

      Donor Lymphocyte Infusion, Allogeneic Hematopoietic Stem Cell Transplantation, Acute Leukemia Trial in Beijing (donor lymphocyte

      Unknown status
      • Donor Lymphocyte Infusion
      • +5 more
      • donor lymphocyte infusion
      • Beijing, Beijing, China
        Peking University Institute of Hematology,Beijing
      Mar 9, 2020